NCT03096392 - Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 18, 2017

Primary Completion Date

November 15, 2017

Study Completion Date

March 18, 2018

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

HDV insulin lispro 100 UNT/ML

HDV is the active excipient, added to insulin lispro. HDV binds to a portion of the insulin lispro.

DRUG

Insulin Lispro 100 UNT/ML

Sterile Water for Injection is added to the insulin lispro, to dilute the insulin lispro equal to the HDV insulin lispro

Trial Locations (5)

Lucas Research, Inc., Morehead City

Baptist Diabetes Associates, Miami

Texas Diabetes and Endocrinology, Austin

Texas Diabetes and Endocrinology, Austin

Barbara Davis Center for Diabetes, University of Colorado, Aurora